Huons Meditech Participates in MEDICA 2025 in Germany
- CE-MDR certified Dermashine line draws strong attention - “Strengthening global presence and expanding new partnerships”
[by Jin, Yu Jeong] Huons Meditech, a medical device subsidiary of Huons Group, showcased its flagship products, including the ‘Dermashine’ series, at one of the world’s leading medical exhibitions.
Huons Meditech announced on the 20th that it took part in ‘MEDICA 2025,’ held in Düsseldorf, Germany, from November 17.
‘MEDICA’ is one of the world’s largest medical device exhibitions, with more than 5,000 companies from over 70 countries participating annually. It is widely recognized as a key global platform to explore the latest technologies and innovations in the medical device sector.
At this year’s exhibition, Huons Meditech strengthened its global network across Europe, the Middle East, and Asia, while actively promoting its products and brand in the medical and aesthetic device markets.
During MEDICA 2025, the company highlighted the excellence of various medical devices, including its Dermashine product lineup (Dermashine Pro and Dermashine Balance). Dermashine is a globally proven aesthetic medical device brand with over 20,000 units sold worldwide, featuring highly precise drug delivery technology and a user-friendly interface. In August, the Dermashine series became the first electrically powered drug delivery device developed by a Korean company to receive CE-MDR certification (Medical Device Regulation). Since then, the company has actively promoted its performance through campaigns emphasizing the importance of using genuine needles.
The extracorporeal shockwave lithotriptor ‘URO-UEMXD,’ which combines a shockwave head and ultrasound in an in-line structure, also attracted significant attention. The URO-UEMXD is the first Korean-made device to combine these two components in a straight in-line configuration, overcoming the limitations of conventional X-ray–based stone localization systems. Huons Meditech also showcased additional products including the endoscope reprocessor ‘HUEN DR-02,’ further highlighting the breadth of its medical device portfolio.
CEO Changwoo Ha stated, “Our participation in MEDICA 2025 has strengthened our presence in the European market and created new opportunities for global collaboration. We will continue to enhance our competitiveness in the global medical device industry through ongoing technological innovation and quality advancement.”
Huons Meditech continues to lay the groundwork for European market expansion through CE-MDR certification and is actively pursuing new partnerships not only in Europe but also across the Middle East and Asia by promoting its technological excellence and product competitiveness.